Adherium Corporate Headquarters Opens in Silicon Valley

SAN MATEO, Calif., Jan. 18, 2018 -- Adherium (ASX:ADR), a digital health company that improves medication adherence and patient outcomes, today announced the opening of its corporate headquarters in San Mateo, California.

“Our headquarters at 1800 Gateway Drive deepens our existing footprint in Silicon Valley, as we take the success we have experienced globally and concentrate it here to meet U.S. demand for solutions that unlock stronger, more seamless partnerships between physicians and their patients,” said Arik Anderson, CEO of Adherium. “Our technology was born in New Zealand and has been embraced globally for asthma and COPD. In California’s tech ecosystem we can accelerate the process of bringing it to its full potential.”

Despite advances in therapies and understanding of respiratory disease, asthma remains the third-leading cause of hospitalization for children under 15 and the leading cause of missed school days in the U.S., resulting in more than $80 billion a year in costs. In arriving at this estimate, the Centers for Disease Control did not include non-medical costs including lost time waiting in a physician’s office and diminished productivity, let alone the hard to calculate cost of children’s potential diminished performance in school or avoidance of activities.

“Our technology leverages a 15-year investment in one of the world’s largest datasets of respiratory medication usage,” said Anderson. “We combine the most clinically proven precision monitoring with low-friction coaching, eliminating hurdles that stand in the way of physicians trying to better guide patients after they’ve stepped out of the practice and become enmeshed in their day-to-day lives. Here in Silicon Valley, our global organization is meeting the promise of that technology.”

About Adherium

Adherium is a provider of digital health solutions and a global leader in connected respiratory medical devices. The Company develops, manufactures and supplies patients, pharmaceutical companies, healthcare providers and contract research organizations with the broadest range of connected medical devices for respiratory medications to address sub-optimal medication use and improve health outcomes in chronic disease. Adherium operates globally from bases in the USA, Europe and Australasia. Learn more at Adherium.com.

Inquiries

Vik Panda, Adherium
Email: [email protected]

Media
Chris Gale, Greentarget
Phone: 646.695.2883
Email: [email protected]

Investors
Leigh Salvo, Gilmartin Group
Phone: 415.937.5404
Email: [email protected]